Skip to main content
ADPT logo

ADPT · Adaptive Biotechnologies Corp · Investor Relations

Track ADPT — free
$29.50 +0.60 (+2.08%)
Market Cap
$4.52B
Shares
159.60M
Volume · Sep 30 1.51M Avg daily vol (55 sessions) 2.36M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-07-29 Adaptive Biotechnologies Second Quarter Financial Results Earnings call
2026-06-03 William Blair 46th Annual Growth Stock Conference Conference
2026-06-02 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Shareholder meeting
2026-05-05 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-05-05 Adaptive Biotechnologies First Quarter Financial Results Event
2026-03-02 TD Cowen 46th Annual Healthcare Conference Conference
2026-02-05 Q4 Earnings conference call (announced in 8-K) Earnings call
2026-02-05 Adaptive Biotechnologies Fourth Quarter Financial Results Event
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-03 Piper Sandler Healthcare Conference Conference
2025-11-19 Jefferies Global Healthcare Conference Conference
2025-11-05 Adaptive Biotechnologies Third Quarter Financial Results Event
2025-09-10 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-05 Adaptive Biotechnologies Second Quarter Financial Results Event
2025-06-11 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-03 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Shareholder meeting
2025-05-01 Adaptive Biotechnologies First Quarter Financial Results Event
2025-04-11 Miami Myeloma MRD Meeting 2025 Event
2025-03-03 TD Cowen 45th Annual Health Care Conference Conference
2025-02-11 Adaptive Biotechnologies Fourth Quarter Financial Results Event
2025-01-15 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-11-07 Adaptive Biotechnologies Third Quarter Financial Results Event
2024-10-02 Endpoints Webinar: The power of antigen-specific TCR signatures in developing next-gen immunotherapies Event
2024-10-01 Fierce Biotech Summit (2024) Event
2024-09-06 Morgan Stanley 22nd Annual Global Healthcare Conference Conference

Source: http://investors.adaptivebiotech.com/

Key facts CIK 1478320 CUSIP 00650F109 13F (30d) 9 filings 9 filers Visit website Investor relations